SEATTLE, Feb. 06, 2019 (GLOBE NEWSWIRE) -- CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article and exclusive CEO interview discussing recent advancements made by Chemesis International Inc. CSI CADMF. In a cannabis industry that is experiencing explosive growth in multiple and diverse geographical markets, it can be difficult for a business to choose its focus and stay on track. A balance must be achieved between building a presence in a key market and diversifying into new opportunities. With its recent run of deals in California, Colombia, and Puerto Rico, Chemesis appears to be achieving that mix.
In an exclusive interview with CFN Media, Part 1 of 2, CEO Edgar Montero discusses the origins of the company, its operations in California, and the launch of the Jay and Silent Bob's Private Stash brand of cannabis products. If the video does not display properly, please follow the link to view on CannabisFN.com: https://www.cannabisfn.com/cfnvideo/?id=0Hy9eKzR
Click here to receive updates on Chemesis developments.
California is Crucial
The legal rollout in California has been happening in fits and starts as municipalities and the state iron out regulations and process a mountain of applications. Companies working in some of the more forward-thinking locales that were early adopters of the new regulations have a leg up in the legal market. Chemesis falls into this category with its California Sap and Desert Zen operations, located in Cathedral City. The two operations are complementary, with California Sap handling extraction and production of extracts and prerolls, and Desert Zen taking care of packaging and distribution. Both companies handle Chemesis' own brands while offering contract services to other brands.
With that infrastructure in place, Chemesis has partnered with Jay and Silent Bob to launch the Private Stash brand, based on the characters from the slacker movie classics directed by Kevin Smith. To supercharge the product launch and to enhance sales of its other brands, Chemesis has engaged Dank City, a specialty cannabis marketing firm boasting the largest network of cannabis social media pages. The goal is to leverage Chemesis' early mover advantage into a comprehensive brand presence throughout the state. With California serving as the world's largest legal cannabis market and considering the state's role in setting cultural trends that resonate across the globe, that goal is certainly a worthy one.
Colombia Coming Along Nicely
With the recent acquisition of licensed cultivator La Finca Interactiva-Arachna Med, Chemesis is diving head first into the emerging Latin American market. The company currently grows on 1,060 acres and also operates a 10,000 sqft greenhouse. It also partners with Universidad Nacional of Colombia to research and develop ideal agricultural practices for the cultivation of cannabis. In short, it's a very early mover in a country that has a fledgling medical marijuana program.
La Finca is commencing construction of a GMP certified extraction and production facility to fill a need for clean and reliable cannabis-derived medicines in the country. By building the operation to the highest standards and working closely with the government every step of the way, Chemesis is ensuring that it can develop a low-cost, high-quality producer with capacity to serve both Colombia and international markets. In the end, the export side of the equation may end up being the largest.
Click here to receive updates on Chemesis developments.
Growth in Puerto Rico
Chemesis has a pattern of developing or acquiring licensed operations in the earliest stages of a developing cannabis market. Its operations in Puerto Rico are no different with its Natural Ventures subsidiary. CEO Edgar Montero and the company played a major role in developing Puerto Rico's legal medical cannabis regulatory framework, and as a result the company serves about 90% of the island's dispensaries. Already boasting a 100,000 sqft cultivation facility and a 35,000 sqft extraction facility, Natural Ventures has been adding to its capabilities and product lines significantly over the last couple of months.
In January, Natural Ventures announced the launch of a natural beverages division to include cannabis-derived beverages. Utilizing its current capabilities, and bringing in ingredients like local honey and coffee beans, the company plans an initial launch of beverages designed to provide an energy boost, a calming effect, and sleep support. Infused, functional drinks are one of the fastest growing sectors of the beverage industry and are generally recognized as a major driver in the next wave of development for the cannabis industry.
In another move that ties in with the beverage play while also capitalizing on a high growth sector of the industry, Chemesis announced that it has begun cultivating high CBD strains of hemp on the island. All of the appropriate licenses are in place, from strain registration through cultivation, manufacturing and distribution. With the passage of the 2018 US Farm Bill, it is anticipated that hemp CBD manufacturers will be able to ship products across the US and territories. With the infrastructure in place, and considering Puerto Rico's favorable climate, Natural Ventures looks to be in a prime position to take advantage of the newly-opening markets for CBD products.
In line with the Puerto Rico CBD developments, Chemesis has also acquired a full line of existing hemp-derived CBD products called Viverian. With existing e-commerce distribution in Arizona, Florida, and Nevada, Chemesis anticipates expanding sales both online and in-store across the US once the state regulations are worked out as a result of the federal Farm Bill. Adding the cultivation and production capacity of its Puerto Rico operations, it's easy to see the framework of a US-wide CBD operation in the not-too-distant future.
Chemesis is Aligned
By zooming out and taking a macro-view of the Chemesis International operation, the unified plan comes into focus. The company is an early mover in the key markets of California and Colombia, positioned not only to do well in those jurisdictions but to spread out from there as regulations allow. With its foothold secured in Puerto Rico, Chemesis not only serves that emerging market (anticipated to grow to 100,000 registered patients by the end of 2019) but should be able to branch out into other US states with its hemp-based offerings. All of its facilities are built with international best practices in mind, and the company has demonstrated its ability to secure all licenses necessary in each jurisdiction. Keep an eye out as Chemesis builds its operation into an international powerhouse.
Click here to receive updates on Chemesis developments.
Please follow the link to read the full article and see the interview: https://www.cannabisfn.com/chemesis-advancing-domestically-and-internationally-plus-exclusive-ceo-interview/
About CFN Media
For Visitors and Viewers
CFN Media's Cannabis Financial Network (CannabisFN.com) is the destination for savvy investors and business people profiting from the worldwide cannabis industry. Viewers will see breaking news, exclusive content and original programming involving the people, companies and investments shaping the industry.
For Cannabis Businesses & Companies
CFN Media is a leading agency and financial media network dedicated to the cannabis industry. We help private, pre-public and public cannabis companies in the US and Canada attract capital, investors and media attention.
Our powerful digital media and distribution platform conveys a company's message and value proposition directly to accredited and retail investors and national media active in the North American cannabis markets.
Since 2013, CFN Media has enabled the world's preeminent cannabis companies to thrive in the capital and public markets.
Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/featuredcompany
Disclaimer
CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on http://www.cannabisfn.com (the ‘Site') is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/
Frank Lane
206-369-7050
flane@cannabisfn.com
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
